ITGB3 and cancer: Cancer cells isolated from ablated tumors showed a markedly reduced clonogenic potential under stem cell-selective conditions (Fig. 4A) and had downregulated the CSC marker CD61/beta-3 integrin25 (Fig. 4B), while the expression of the CSC marker CD29/beta-1 integrin26 was not affected (Fig. 4C).